newsmetry
rusign inget started
macro

Guggenheim keeps Buy ratings on Six Flags, Northrop Grumman and Kroger

Guggenheim reiterated Buy ratings on Six Flags, Northrop Grumman and Kroger, with price targets of $17, $640 and $68, per TradingView.

published on Newsmetry
original source published

the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →

Newsmetry newsroom

what happened

Guggenheim reiterated its Buy rating on three companies, according to TradingView, which cites Benzinga data. Its price target for Six Flags Entertainment is $17, implying a 116.3% gain from the October 20 close of $7.86.

For Northrop Grumman, the target is $640, an implied upside of 19.9% from the $534 close. The analyst points to 2027 revenue growth guidance of 5-7%, a record backlog of $109.6 billion and core programs fully funded within the FY27 budget.

For Kroger, the target is $68, an implied upside of 8.0% from the $62.98 close. The note cites updated growth targets for food comp sales and EBITDA, and an EV/EBITDA multiple of 6.5x on 2026 estimates, versus a five-year average of about 7.1x.

why it matters

Reports like these concern individual stocks and usually have limited effect on the broader market. They offer a view of analyst sentiment across entertainment, defense and grocery retail. This is not investment advice.

tags

Analyst RatingStockUnited States

instruments

Six Flags EntertainmentNorthrop GrummanKroger

sources

  1. Guggenheim maintains Buy rating on Six Flags Entertainment, $17 price target — TradingView, 21 October 2026 at 13:13 UTC
  2. Guggenheim maintains Buy rating on Northrop Grumman, $640 price target — TradingView, 21 October 2026 at 13:17 UTC
  3. Guggenheim maintains Buy rating on Kroger, $68 price target — TradingView, 21 October 2026 at 13:15 UTC
  4. Six Flags Entertainment Is Maintained at Buy by Guggenheim — Dow Jones Newswires, 21 October 2026 at 13:23 UTC
  5. Guggenheim maintains Buy rating on Rapport Therapeutics, $70 price target — TradingView, 21 October 2026 at 13:29 UTC

prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.

the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.

get stories in real time ↗

related stories